Drug Safety Update Feb 2010

admin February 15th, 2010

Drug Safety Update has been issued, including the following safety advice

  • Tacrolimus: new oral liquid (Modigraf); formulations not interchangeable without careful therapeutic monitoring.
  • Yellow Card Scheme update
  • Problem with postal delivery of Yellow Cards.
  • Swine flu portal update
  • Suspected adverse reactions to flu antivirals and vaccines confirm recognised safety profile.
  • Orlistat safety update.
  • Nicotine replacement therapy and harm reduction.
  • Sibutramine: suspension of EU licenses recommended as evidence indicates risks outweigh benefits.
  • Off-label intraocular use of recombinant tissue plasminogen activator: risk of intraocular lens opacification.
  • Please report suspected adverse reactions associated with intra-articular use of local anaesthetics.

Comments are closed.